Product Images Prochlorperazine Edisylate
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 6 images provide visual information about the product associated with Prochlorperazine Edisylate NDC 51662-1558 by Hf Acquisition Co Llc, Dba Healthfirst, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
POUCH LABELING - 51662 1558 2 Pouch Label
Case Labeling - 51662 1558 3 Case Labeling
RFID LABELING - 51662 1558 3 RFID Label
Boxed Warning - Boxed Warning
The text describes a warning about the use of antipsychotic drugs in elderly patients with dementia-related psychosis. Such patients treated with these drugs are at higher risk of death due to cardiovascular and infectious causes. The risk of death is higher in those taking atypical antipsychotic drugs than in those taking a placebo. The extent to which the risk is caused by the drug or patient characteristics is not clear. The warning states that the use of Prochlorperazine Edisylate Injection, USP is not approved for such patients.*
STRUCTURE - STRUCTURE
VIAL LABEL - Vial Label
This is a label for a medication with the NDC code 23155-294-31. It advises that the medication should be protected from light. The medication is Prochlorperazine with a manufacturing license number G/28/1655. The medication is manufactured by Emcure Pharmaceuticals Ltd. in Sanand, Ahmedabad, with a concentration of 10 mg/2 mL. The medication is not for subcutaneous use and comes in a 2 mL multiple-dose vial, available by prescription only from Avet Pharma.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.